However, no significant correlation was observed between plasma chitotriosidase levels and MS severity metrics in the overall population, except for the higher levels in treatment naïve patients with worse prognosis, as indicated by a higher MSSS score (p = 0.028) (Table 3). Here, CHIT1 is linked to myeloid sarcoma.